Results 71 to 80 of about 245,026 (162)

Clearing the bar: adding anti-VEGF therapy to chemoimmunotherapy for biliary tract cancer. [PDF]

J Gastrointest Oncol
King G, Sahai V.
europepmc   +1 more source

Effects of anti-VEGF therapy on choroidal thickness in eyes with diabetic macular edema. [PDF]

BMC Ophthalmol
Shi XN, Zhang QY, Ju CJ, Xu YC, Xiong ZH.   +4 more
europepmc   +1 more source

Factors Involved in Anti-VEGF Treatment Decisions for Neovascular Age-Related Macular Degeneration: Insights from Real-World Clinical Practice

Clinical Ophthalmology
Glenn Yiu,1 Shilpa Gulati,2 Victoria Higgins,3 Emily Coak,3 Daniel Mascia,3 Eunice Kim,4 Galin Spicer,4 David Tabano4 1Department of Ophthalmology & Vision Science, University of California, Davis Health, Sacramento, CA, USA; 2New England Retina ...
Yiu G, Gulati S, Higgins V, Coak E, Mascia D, Kim E, Spicer G, Tabano D   +7 more
doaj  

Impact of Comorbid Hypertension and Diabetes on Anti-VEGF Treatment Outcomes in Macular Edema. [PDF]

J Ophthalmol
Lu W, Yang S, Zheng C, Wu Z.
europepmc   +1 more source

Eye Drop Development of Anti-VEGF Therapeutics by Ocular Penetrating Carrier to the Posterior Region of the Eye. [PDF]

Transl Vis Sci Technol
Chiueh VC, Lee LL, Tau S, Luu M, Park JH, Lee T.   +5 more
europepmc   +1 more source

Real-World Persistence with Anti-VEGF Therapy in Neovascular Age-related Macular Degeneration. [PDF]

Ophthalmol Ther
Elham A, Liu H, Li W, Zhao J, Yang X, Zeng C, Meng X.   +6 more
europepmc   +1 more source

Anti-VEGF safety in evolution: A comprehensive review of ocular and systemic considerations. [PDF]

Indian J Ophthalmol
Venkatesh R, Biradar P, Malwe G, Prabhu V, Hande P, Kathare R, Raj P, Roy R, Yadav NK, Jayadev C.   +9 more
europepmc   +1 more source

Prognostic Imaging Biomarkers in Diabetic Macular Edema Treated with Anti-VEGF: A Multicenter AI Perspective. [PDF]

Ophthalmol Ther
Parravano M, Ferro Desideri L, Costanzo E, Eldridge N, Zinkernagel M, Anguita R, Sacconi R, Querques G.   +7 more
europepmc   +1 more source

Suboptimal Responses to Anti-VEGF in Retinal Neurovascular Diseases: Linking Aging and Alternative Angioinflammatory Pathways. [PDF]

Invest Ophthalmol Vis Sci
Piroozmand S, Latifi-Navid H, Soheili ZS, Hosseinkhani S, Samiei S, Barzegar Behrooz A, Ahmadieh H, Leonardi A, Ghavami S, Sheibani N.   +9 more
europepmc   +1 more source

Ophthalmic Application of Anti-VEGF Therapy

Asia-Pacific Journal of Ophthalmology, 2017
Timothy Y Y, Lai, Chui Ming Gemmy, Cheung, William F, Mieler   +2 more
openaire   +2 more sources